Tyler-Stone Wealth Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
$1K Hold
750
﹤0.01% 817
2022
Q3
$2K Hold
750
﹤0.01% 762
2022
Q2
$2K Hold
750
﹤0.01% 773
2022
Q1
$5K Hold
750
﹤0.01% 674
2021
Q4
$6K Buy
+750
New +$6K ﹤0.01% 679